Thomas M. Habermann, M.D.

Departments

Cancer CenterHematology

Location

  1. Rochester, Minnesota
  • Malignant Lymphomas
  • Hodgkins disease
  • Hairy cell leukemia
  • Post-transplant lymphoproliferative disorders

Rochester, Minnesota

  1. 1985
    Fellow - HematologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  2. 1982
    Resident - Internal MedicineMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  3. 1979
    MDCreighton University
  4. 1975
    BS - BiologyCreighton University

Awards and Honors

  1. 2014
    The Leading Physicians of the WorldLeading Physicians of the World
  2. 2013
    Henry S. Plummer Distinguished Physician AwardDepartment of Medicine Clinical Research Office Subcommittee, Department of Internal Medicine
  3. 2012
    2012 Lifetime Achievement for Outstanding Contributions to Medical Education AwardDepartment of Internal Medicine
  4. 2010
    Department of Medicine Laureate AwardDepartment of Medicine Clinical Research Office Subcommittee, Department of Internal Medicine
  5. 2009
    Distinguished Contribution to Medical EducationDepartment of Internal Medicine
  6. 2009
    Distinguished Mayo EducatorMayo Clinic
  7. 2008
    Minnesota Hope AwardLymphoma Research Foundation
  8. 2008
    Fellow American College of PhysiciansAmerican College of Physicians
See more

Professional Memberships

  1. 2007 - present
    MemberExecutive Committee, Lymphoma Research Foundation
  2. 2006 - present
    MemberScientific Advisory Board, Lymphoma Research Foundation
  3. 2005 - present
    MemberLymphoma Research Foundation
  4. 2005
    MemberProgram Committee, Lymphoma Research Foundation
  5. 2004 - present
    MemberFrontier Science Board of Directors, Eastern Cooperative Oncology Group
  6. 2000
    Associate EditorMayo Internal Medicine Board Review Book, Mayo Foundation for Medical Education and Research
  7. 2000 - present
    Editorial Board MemberAmerican Society of Clinical Oncology
  8. 2000 - present
    Advisory Board MemberEastern Cooperative Oncology Group
See more